PATENT CLAIM ANALYSIS

Application Number: 15749886
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["424", "489000"]

Abstract:
The present invention relates to mesoporous calcium phosphate-citrate nanoparticles, optionally comprising a lipid membrane, and pharmaceutical compositions thereof. The present invention further relates to a method of synthesizing the mesoporous calcium phosphate-citrate nanoparticles. The present invention relates to their use as drug delivery system. The present invention further relates to medical uses as bone or teeth cement, bone material or taste or non-taste masked carrier or delivery system. The present invention relates to the use of the mesoporous calcium phosphate-citrate nanoparticles in the diagnosis and/or treatment of cancer. The present invention further relates to the use of the mesoporous calcium phosphate-citrate nanoparticles in fertilizer or absorber of metal ions from wastewater and/or water.

Claim (Index 21):
The method according to  claim 19 , wherein the nanoparticles are released in cancerous cells, from an endosome into the cytosol and nucleus.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 88.0
- Lexical Diversity: 2.25926
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14131575', '15613847', '13140855', '15798287', '13388538']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7232506943355131
- 35 USC 102 Novelty (BERT): 0.5123907947628447
- Combined Prediction Score: 0.7021647043782463
- Mean Citation Score: 223.759982
- Max Citation Score: 230.8395
- Similarity Product: 132.77445487698913

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test